The proton pump inhibitors (PPI) are used in the management of gastric and duodenal ulcers and more recently for gastro-oesophageal reflux (GOR). They are also used to treat the Zollinger-Ellison syndrome, which is due to hypersecretion of gastrin by the stomach. Finally, they are widely prescribed in the prevention and management of peptic problems due to the non-steroidal anti-inflammatory drugs (NSAID).
The PPI inhibit the pump which produces acidity in the stomach (the proton pump) and therefore regulate the production of acid at its source. They are absorbed in the small intestine and block the acid secretion of cells in the stomach wall. They are generally administered as a single daily dose in the morning or evening as indicated. Morning and evening doses may be prescribed in a few specific situations.
The PPI for gastro-œsophageal reflux. © Phovoir